These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7252216)

  • 21. [Modern view on drug therapy of tuberculosis].
    Douma J
    Ned Tijdschr Geneeskd; 1972 Oct; 116(41):1864-5. PubMed ID: 4640232
    [No Abstract]   [Full Text] [Related]  

  • 22. Three-in-one TB drug approved.
    Posit Aware; 1995; ():5. PubMed ID: 11362378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
    Vásquez-Campos L; Asencios-Solis L; Leo-Hurtado E; Quispe-Torres N; Salazar-Lindo E; Bayona J; Becerra MC
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):465-72. PubMed ID: 15141740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide].
    Brändli O; Dreher D; Morger D
    Schweiz Med Wochenschr; 1993 Jun; 123(25):1300-6. PubMed ID: 8341998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 27. Genitourinary tuberculosis: a 7-year review.
    Gow JG
    Br J Urol; 1979 Aug; 51(4):239-44. PubMed ID: 465996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
    Visser ME; Texeira-Swiegelaar C; Maartens G
    Int J Tuberc Lung Dis; 2004 Feb; 8(2):260-2. PubMed ID: 15139457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative Mycobacterium tuberculosis infection after total knee arthroplasty.
    Lee CL; Wei YS; Ho YJ; Lee CH
    Knee; 2009 Jan; 16(1):87-9. PubMed ID: 18974007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New TB drug approved.
    AIDS Patient Care; 1995 Feb; 9(1):42. PubMed ID: 11361363
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for short-course tuberculosis chemotherapy. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control Atlanta, Ga.
    Conn Med; 1980 Aug; 44(8):516-8. PubMed ID: 6249535
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
    Iukhimenko NV
    Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Good news and not such good news.
    Iseman MD
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):87. PubMed ID: 10091871
    [No Abstract]   [Full Text] [Related]  

  • 38. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
    Jasmer RM; Snyder DC; Saukkonen JJ; Hopewell PC; Bernardo J; King MD; Kawamura LM; Daley CL;
    Clin Infect Dis; 2004 Feb; 38(3):363-9. PubMed ID: 14727206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental study of rifampicin and ethambutol].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1971; 49(1):64-8. PubMed ID: 5576515
    [No Abstract]   [Full Text] [Related]  

  • 40. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.